Literature DB >> 12037095

Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.

Paolo Scarpellini1, Paola Carrera, Annalisa Cavallero, Massimo Cernuschi, Gianni Mezzi, Pier Alberto Testoni, Anna Zingale, Adriano Lazzarin.   

Abstract

One hundred forty gastric biopsies were tested by microbiological methods and by amplifying a sequence of 23S rRNA and identifying mutations associated to clarithromycin resistance. Seventy-six specimens were positive for Helicobacter pylori. Mutational analysis revealed alterations in 18 (39.1%) of 46 and 2 (8.7%) of 23 samples from human immunodeficiency virus-seropositive and -seronegative persons, respectively. The results of the mutational analysis fully correlated with those of the susceptibility tests.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12037095      PMCID： PMC130724          DOI： 10.1128/JCM.40.6.2234-2237.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.

Authors:  S Maeda; H Yoshida; K Ogura; F Kanai; Y Shiratori; M Omata
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

3.  Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material.

Authors:  B Björkholm; R Befrits; B Jaup; L Engstrand
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori.

Authors:  G G Stone; D Shortridge; J Versalovic; J Beyer; R K Flamm; D Y Graham; A T Ghoneim; S K Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.

Authors:  K Hultén; A Gibreel; O Sköld; L Engstrand
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 6.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

7.  Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.

Authors:  A Occhialini; M Urdaci; F Doucet-Populaire; C M Bébéar; H Lamouliatte; F Mégraud
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 8.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

9.  Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR.

Authors:  E Sevin; D Lamarque; J C Delchier; C J Soussy; J Tankovic
Journal:  FEMS Microbiol Lett       Date:  1998-08-15       Impact factor: 2.742

Review 10.  Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.

Authors:  F Mégraud; H P Doermann
Journal:  Gut       Date:  1998-07       Impact factor: 23.059
View more
  5 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

Authors:  O Y Misyurina; E V Chipitsyna; Y P Finashutina; V N Lazarev; T A Akopian; A M Savicheva; V M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.

Authors:  Yong Jiang; Hui Zhu; Li-Na Yang; Yuan-Jun Liu; Shu-Ping Hou; Man-Li Qi; Quan-Zhong Liu
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

4.  Coinfection: Helicobacter pylori/human immunodeficiency virus.

Authors:  Martin Olmos; Valentina Araya; Eduardo Pskorz; Eduardo Coronado Quesada; Hugo Concetti; Hector Perez; Pedro Cahn
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 5.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.